October 22, 2018 Intec Pharma Completes Enrollment of Pivotal Phase 3 Clinical Trial of Accordion Pill™ Carbidopa/Levodopa for the Treatment of Advanced Parkinson’s Disease Patients View Article
March 12, 2018 Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson’s Disease View Article
January 31, 2018 Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer View Article
January 8, 2018 Intec Pharma Announces Development Collaboration With Global Pharmaceutical Company View Article
August 16, 2017 Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares View Article
August 3, 2017 Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies View Article
May 24, 2017 Intec Pharma Granted U.S. Patent for Accordion Pill™ Comprising Levodopa for Improved Treatment of Parkinson’s Diseases Symptoms View Article
